Benefits of Empagliflozin in Patients With Heart Failure and Reduced Ejection Fraction Without Diabetes Mellitus
Clinical trial NCT06632561 · COMPLETED
Trial details
- NCT number
- NCT06632561
- Sponsor
- Ashraf Wasfy Beshay Aziz
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2022-03-09
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.